Pharmaceutical Manufacturing

Melissa previously served as the chief quality officer for Bristol Myers Squibb. In this role, she led the GPS Quality organization in setting the quality compliance strategy, implementation of quality processes and systems, and development of talent to ensure the highest level of quality and compliance. Before joining Bristol Myers Squibb, Melissa was also the chief quality officer at Biogen. She has had prior roles providing oversight for QC laboratories and spent several years as the vice president of Corporate Quality, with responsibility for global compliance and quality systems as well as in-market Quality.

Melissa earned a Bachelor of Science degree in Biological Sciences and Biochemistry from North Carolina State University and an Executive Master of Business Administration degree from Duke University. She has over 25 years of experience in the quality arena, including quality positions at Novo Nordisk and Glaxo Smith Kline.

Melissa has been involved in influencing regulatory guidance through her participation on non-profit Boards of the Parenteral Drug Association since 2016, currently serving as chair-elect; as well as Rx-360 consortium focused on supply chain security vis-à-vis public health concerns and patient safety. She has been an advocate for simplification of post approval change processes, participating in industry forums, writing articles and interacting with regulators. She holds certifications from ASQ as a Certified Quality Auditor, Quality Engineer and Quality Manager.